Plastic peril in Sundarbans: Microplastics found in fishing cat scat, soil, water and prey
KOLKATA
:
A study has laid bare the presence of plastic in scat samples of fishing cats in the Indian Sundarbans, indicating how far the non-biodegradable pollutant has penetrated the fragile ecosystem.
Plastic was also found in their environmental and dietary components like soil, water, vegetation, rodents, fish and crabs. The plastic includes both high- and low-density polyethylene and the study follows similar exposes on the presence of heavy metals in the
Sundarbans ecosystem
. Experts blame tourism, unused fishing nets discarded in the islands and industrial influx from Kolkata for the magnitude of the problem.
'Microplastics detected in the scat samples of fishing cats are mainly fibres with some beads and pellets, foam, sheets and fragments. The sizes ranged between 0.1 and 0.9mm. An analysis confirmed that the majority of microplastics were composed of high-density polyethylene, low-density polyethylene and polypropylene, polyethylene terephthalate, poly-ether, and diglycidyl ethers that are common constituents of plastic pollution originating from tourist and industrial waste,' said Samrat Chakraborty of Calcutta University's dept of zoology, who led the study.
Professor Goutam Kumar Saha of dept of zoology, CU, and Dr Tanoy Mukherjee of Indian Statistical Institute along with Joydip Kundu of city-based NGO SHER were the co-principal investigators.
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Google Brain Co-Founder Andrew Ng, Recommends: Read These 5 Books And Turn Your Life Around
Blinkist: Andrew Ng's Reading List
Undo
The study — conducted at Pakhiralay, Patharpratima, Lothian Wildlife Sanctuary and Henry's Island with the Wildlife Conservation Trust's BEES Grants — identified unscientific tourism loads and random littering (of plastic packets and bottles) plus nets discarded by fisherfolk as the microplastic sources.
Plastic pollution could lead to gastrointestinal problems in fishing cats, Bengal's state animal, Chakraborty said. 'This can also result in behavioural changes that may impact their hunting practices. These toxins can cause severe damage to the reproductive cycles, resulting in poor litter numbers or babies with imm-unological problems. All these may impact the fishing cat population in the near future,' he added.
The same study earlier detected the presence of heavy metals like lead and chromium in fishing cat scat samples and the environment.
The team has also conducted two awareness camps in the Sundarbans. Teachers from forest fringes participated in the camp at Pakhiralay, where they focused on the pollutants' toxic effects. The team conducted a clean-up drive at the Bhagabatpur Crocodile Sanctuary.
Awareness camps, too, were held in 12 South Bengal districts to reach out to a wider audience of grassroots communities, teachers, fishermen, boatmen, students and other stakeholders and make them aware of the ecological significance of fishing cats and the need for their conservation, Chakraborty said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
5 days ago
- The Hindu
M. Krishnamurthy to speak at Chicago university conference
The University of Chicago Library will host the 20th International Open Repositories Conference (IORC) from June 15–18, 2025. The theme of this year's conference is 'Twenty Years of Progress, a Future of Possibilities.' M. Krishnamurthy, professor, Indian Statistical Institute, Bengaluru, has been invited to speak at the event. He has also been selected as one of the fellows of the University of Chicago, U.S. During the conference, he will deliver a lecture on Research Data Management in Social Science.
Time of India
15-05-2025
- Time of India
FaceAge AI tool can predict cancer survival from your selfie; here's how
FaceAge AI tool can predict cancer survival from your selfie; here's how Artificial intelligence (AI) is rapidly transforming healthcare, with new tools emerging that can assess patients' health in innovative ways. One of the latest advancements is FaceAge , an AI-driven system capable of estimating a person's biological age—a measure of how their body is aging—using just a facial photograph. Unlike chronological age, which simply counts the number of years a person has lived, biological age reflects the cumulative wear and tear on the body, influenced by genetics, lifestyle, and environment. This new approach could provide a more accurate assessment of overall health, potentially improving patient care and survival predictions, particularly for cancer patients. Recently published in The Lancet Digital Health, a groundbreaking study titled 'FaceAge, a deep learning system to estimate biological age from face photographs to improve prognostication' demonstrated that FaceAge can even predict cancer survival more accurately than many current clinical methods. What is FaceAge and how does it work FaceAge is a deep learning system developed by researchers at Harvard Medical School and other leading institutions. It uses advanced image processing and machine learning techniques to analyze facial photographs and estimate a person's biological age. Unlike traditional age estimation, which focuses on chronological years, FaceAge assesses the physiological signs of aging captured in facial features. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like AI guru Andrew Ng recommends: Read These 5 Books And Turn Your Life Around in 2025 Blinkist: Andrew Ng's Reading List Key features of FaceAge: Data-driven insights : Trained on a dataset of over 58,000 facial images from healthy individuals, and tested on 6,196 cancer patients across multiple hospitals in the United States and Europe. Biological age measurement : Goes beyond surface appearance, examining deep, structural changes in facial tissues and skin to assess biological aging. Genetic links : Identifies biological age markers linked to genes associated with cellular senescence and overall longevity, providing insights into aging at the molecular level. Advanced image analysis : Uses sophisticated algorithms to detect subtle facial changes that correspond to biological aging, such as skin elasticity, bone density, and muscle tone. How FaceAge predicts cancer survival One of the most significant findings in the recent study is that FaceAge can predict cancer survival more accurately than doctors relying on traditional metrics like chronological age. The study divided cancer patients into three major groups: Curative patients : Those receiving potentially curative treatments, primarily radiation therapy. Thoracic cancer patients : Those with cancers affecting the chest, including lung and esophageal cancers. Palliative patients : Those with advanced-stage or metastatic cancers, often in palliative care settings. In all three groups, FaceAge consistently outperformed traditional age in predicting survival outcomes. Notably, it was able to detect the accelerated aging associated with cancer progression, which often goes unnoticed by conventional assessments. Key findings: Curative group : Higher FaceAge scores were linked to significantly lower survival rates, suggesting that patients who appear biologically older are less likely to survive despite aggressive treatment. Thoracic group : FaceAge provided more accurate survival predictions, even when doctors had full clinical data, highlighting the tool's potential for personalized cancer care . Palliative group : In patients receiving end-of-life care, FaceAge improved survival predictions when integrated with established clinical tools like the TEACCH model, allowing for better care planning. Why biological age matters in cancer prognosis Chronological age often fails to capture the true health status of a patient. Two people of the same age can have vastly different biological ages depending on lifestyle, genetics, and medical history. This discrepancy is particularly relevant in cancer care, where treatment decisions must balance the potential benefits against the physical toll on a patient. Key advantages of biological age measurement: Personalised treatment : Allows for more tailored treatment plans based on a patient's actual biological condition, not just their birth date. Improved survival predictions : Identifies patients at higher risk of poor outcomes, enabling more proactive interventions. Reduced treatment risks : Helps avoid overtreatment in biologically older patients who may not tolerate aggressive therapies. Potential impact on healthcare and cancer treatment FaceAge has the potential to revolutionise how oncologists assess patient fitness for treatment. By providing a clearer picture of biological aging, it could lead to more precise and personalized treatment strategies. However, the technology is still in its early stages and will require further testing across diverse populations before it can be widely adopted. Future applications: Clinical trials : Could be used to stratify patients more effectively, improving the quality of clinical research. Remote health monitoring : Offers a non-invasive, image-based method for ongoing health assessments. Elderly care : May help in assessing frailty and fall risk in older adults. Ethical and privacy concerns Despite its potential, FaceAge raises several ethical concerns. Using facial images to assess health introduces privacy risks, as this data could be misused by employers, insurers, or even governments. Researchers have also warned that the AI model might produce biased results if not properly calibrated for different races, genders, and age groups. Challenges and considerations: Data privacy : Protecting sensitive medical and facial data from misuse. Algorithmic fairness : Ensuring the model performs accurately across diverse populations. Regulatory oversight : Developing clear guidelines to prevent misuse and ensure transparency. AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
15-05-2025
- Time of India
Can a hormone reverse fatty liver disease? Here's what experts think
Researchers at Oklahoma University found that the hormone FGF21 can reverse fatty liver disease. The hormone signals the brain to improve liver function. It lowers liver fat and reverses fibrosis. The hormone also lowers cholesterol. This discovery could lead to new drugs for treating fatty liver disease. Clinical trials are showing good therapeutic benefits. Fatty liver disease is rising as a global health concern. Often considered a 'silent' disease as it shows few or no symptoms, fatty liver disease, however, can get serious, depending on its cause and progression. A new study has found that a certain hormone can reverse fatty liver disease . A groundbreaking study by the researchers at the University of Oklahoma found that a hormone can reverse the effects of fatty liver disease in mice. The study is published in Cell Metabolism . What is fatty liver disease? Fatty liver, medically known as hepatic steatosis, is a condition in which fat builds up in the liver. There are two major types of fatty liver disease: alcoholic fatty liver disease (AFLD) and nonalcoholic fatty liver disease (NAFLD). AFLD, as the name suggests, occurs in people who drink large amounts of alcohol. NAFLD, on the other hand, affects people who drink little or no alcohol. Though the cause of nonalcoholic fatty liver disease (NAFLD) is unknown, people who have type 2 diabetes, or prediabetes, obesity, are middle-aged or older, have high blood pressure, are prone to the disease. How does the hormone control fatty liver disease? The researchers found that the hormone FGF21 (fibroblast growth factor 21) can reverse fatty liver disease . The hormone works primarily by signaling the brain to improve liver function . Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Google Brain Co-Founder Andrew Ng, Recommends: Read These 5 Books And Turn Your Life Around Blinkist: Andrew Ng's Reading List Undo They delved into how FGF21 acts on the brain to influence liver metabolism. Understanding the mechanism of action of the hormone could become instrumental as a target for a new class of highly anticipated drugs that are in Phase 3 clinical trials. 'Fatty liver disease, or MASLD (metabolic dysfunction-associated steatotic liver disease), is a buildup of fat in the liver. It can progress to MASH (metabolic dysfunction-associated steatohepatitis) during which fibrosis and, ultimately, cirrhosis can occur. MASLD is becoming a very big problem in the United States, affecting 40% of people worldwide, and there is currently only one treatment approved by the Food and Drug Administration to treat MASH. A new class of drugs, based on FGF21 signaling, is showing good therapeutic benefits in clinical trials, but until now, the mechanism for how they work has been unclear,' Matthew Potthoff, Ph.D., the lead author and a professor of biochemistry and physiology at the University of Oklahoma College of Medicine and deputy director of OU Health Harold Hamm Diabetes Center said in a statement. Fatty liver diet: Best and worst foods for your liver The findings showed that FGF21 was effective at causing signaling in the model species that changed the liver's metabolism. The researchers found that this process lowered the liver's fat, and the fibrosis too was reversed. The hormone also sent a separate signal directly to the liver, specifically to lower cholesterol. 'It's a feedback loop where the hormone sends a signal to the brain, and the brain changes nerve activity to the liver to protect it. The majority of the effect comes from the signal to the brain as opposed to signaling the liver directly, but together, the two signals are powerful in their ability to regulate the different types of lipids in the liver,' Potthoff added. Similar to the GLP-1s (glucagon-like peptide 1) weightloss drugs that regulate blood sugar levels and appetite, FGF21 acts on the brain to regulate metabolism. Interestingly, both are hormones produced from peripheral tissues: GLP-1 from the intestine and FGF21 from the liver, and both work by sending a signal to the brain. 'It is interesting that this metabolic hormone/drug works primarily by signaling to the brain instead of to the liver directly, in this case. FGF21 is quite powerful because it not only led to a reduction of fat, but it also mediated the reversal of fibrosis, which is the pathological part of the disease, and it did so while the mice were still eating a diet that would cause the disease. Now, we not only understand how the hormone works, but it may guide us in creating even more targeted therapies in the future,' the lead author added. Future-Proof Your Child with AI Skills | Limited Early Bird Seats – 33% OFF! | WhatsApp: 9560500838
